Toll-like receptor signaling and subsequent activation of NF-κB-and MAPK-dependent genes during infection play an important role in antimicrobial host defense. The YopJ protein of pathogenic Yersinia species inhibits NF-κB and MAPK signaling, resulting in blockade of NF-κB-dependent cytokine production and target cell death. Nevertheless, Yersinia infection induces inflammatory responses in vivo. Moreover, increasing the extent of YopJ-dependent cytotoxicity induced by Yersinia pestis and Yersinia pseudotuberculosis paradoxically leads to decreased virulence in vivo, suggesting that cell death promotes anti-Yersinia host defense. However, the specific pathways responsible for YopJ-induced cell death and how this cell death mediates immune defense against Yersinia remain poorly defined. YopJ activity induces processing of multiple caspases, including caspase-1, independently of inflammasome components or the adaptor protein ASC. Unexpectedly, caspase-1 activation in response to the activity of YopJ required caspase-8, receptor-interacting serine/threonine kinase 1 (RIPK1), and Fas-associated death domain (FADD), but not RIPK3. Furthermore, whereas RIPK3 deficiency did not affect YopJ-induced cell death or caspase-1 activation, deficiency of both RIPK3 and caspase-8 or FADD completely abrogated Yersinia-induced cell death and caspase-1 activation. Mice lacking RIPK3 and caspase-8 in their hematopoietic compartment showed extreme susceptibility to Yersinia and were deficient in monocyte and neutrophil-derived production of proinflammatory cytokines. Our data demonstrate for the first time to our knowledge that RIPK1, FADD, and caspase-8 are required for YopJ-induced cell death and caspase-1 activation and suggest that caspase-8-mediated cell death overrides blockade of immune signaling by YopJ to promote anti-Yersinia immune defense.
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innate immunity | apoptosis | programmed necrosis | macrophage | pyroptosis T he innate immune response forms the first line of defense against pathogens. Microbial infection triggers the activation of pattern recognition receptors, such as Toll-like receptors (TLRs) on the cell surface or cytosolic nucleotide binding domain leucine-rich repeat family proteins (NLRs) (1) . TLRs induce NF-κB and MAPK signaling to direct immune gene expression, whereas certain NLRs direct the assembly of multiprotein complexes known as inflammasomes that provide platforms for caspase-1 or -11 activation (2) . Active caspase-1 and -11 mediate cleavage and secretion of the IL-1 family of proteins and a proinflammatory cell death termed pyroptosis. However, microbial pathogens can interfere with various aspects of innate immune signaling, and the mechanisms that mediate effective immune responses against such pathogens remain poorly understood. Pathogenic Yersiniae cause diseases from gastroenteritis to plague and inject a virulence factor known as YopJ, which inhibits NF-κB and MAPK signaling pathways in target cells (2) (3) (4) . YopJ activity inhibits proinflammatory cytokine production (4) and induces target cell death (5) . YopJ activity induces processing of multiple caspases, including caspases-8, -3, -7, and -1 (6) (7) (8) . Nevertheless, Yersinia-infected cells exhibit properties of both apoptosis and necrosis (9, 10) , and no specific cellular factors have been identified as being absolutely required for YopJ-induced caspase activation and cell death. We previously found that the inflammasome proteins NLR CARD 4 (NLRC4), NLR Pyrin 3 (NLRP3), and apoptosis-associated speck-like protein containing a CARD (ASC), are dispensable for YopJ-induced caspase-1 processing and cell death (11) . Thus, additional pathways likely mediate YopJ-induced caspase-1 activation and cell death.
Death receptors, such as TNF receptor and Fas, mediate caspase-8-dependent apoptosis via a death-inducing signaling complex containing receptor-interacting serine/threonine kinase 1 (RIPK1), caspase-8, and Fas-associated death domain (FADD) (12, 13) . Whether these proteins are required for Yersinia-induced cell death, and whether this death contributes to antibacterial immune responses, is not known. The Ripoptosome complex, which contains RIPK1, FADD, caspase-8, as well as RIPK3 and cFLIP, regulates apoptosis, programmed necrosis,
Significance
Pathogenic organisms express virulence factors that can inhibit immune signaling pathways. Thus, the immune system is faced with the challenge of eliciting an effective inflammatory response to pathogens that actively suppress inflammation. The mechanisms that regulate this response are largely undefined. The Yersinia virulence factor YopJ blocks NF-κB and MAPK signaling, resulting in reduced cytokine production and target cell death. Here, we find that caspase-8, RIPK1, and FADD are required for YopJ-induced cell death and show that mice lacking caspase-8 are severely susceptible to Yersinia infection and have defective proinflammatory cytokine production. These findings highlight a possible mechanism of immune defense that can overcome pathogen inhibition of cell-intrinsic proinflammatory immune responses.
and survival in response to various stimuli including signaling by the TLR adaptor TRIF (14, 15) . Because YopJ-induced cell death is inhibited in the absence of either TLR4 or TRIF (17) we sought to determine whether YopJ-dependent cell death and caspase-1 activation is regulated by caspase-8 or RIPK3 and to define the role of YopJ-dependent cell death in host defense. Here, we describe a previously unappreciated requirement for RIPK1, FADD, and caspase-8, but not RIPK3, in YopJ-induced caspase-1 activation and cell death. Critically, loss of caspase-8 in the hematopoietic compartment resulted in a failure of innate immune cells to produce proinflammatory cytokines in response to Yersinia infection and severely compromised resistance against Yersinia infection. Our data suggest that caspase-8-mediated cell death in response to blockade of NF-κB/MAPKs by YopJ allows for activation of host defense against Yersinia infection. This cell death may thus enable the immune system to override inhibition of immune signaling by microbial pathogens.
Results

RIPK1
Is Required for Yersinia-Induced Cell Death and Caspase-1 Activation. Activation of multiple caspases, including caspase-1, -3, -7, and -8, is triggered owing to YopJ activity in Yersiniainfected cells (6, 7, 11, 16) . Casp1 −/− Casp11 −/− bone marrowderived macrophages (BMDMs) exhibit a significant delay in cell death in response to Yersinia pseudotuberculosis (Yp), whereas both Yp-induced cell death and caspase-1 activation are indistinguishable between B6 and Casp11 −/− or 129SvImJ BMDMs ( Fig. S1 A-C and Table S1 ). These data suggest that caspase-1 plays a functional role in YopJ-induced cell death. Surprisingly, NLRC4, NLRP3, ASC, and type I IFN receptor alpha are dispensable for Yersinia-induced caspase-1 processing and cell death, suggesting that these events occur via a distinct pathway ( RIPK1, RIPK3, caspase-8, and FADD regulate cell survival and death fate decisions downstream of TRIF as a result of RIP homotypic interaction motif-driven interactions between TRIF and RIPK1 (15, 19) . This interaction can promote apoptosis through a RIPK1/FADD/caspase-8 complex (20) , or programmed necrosis via RIPK1 and RIPK3 (21) . We therefore investigated the potential involvement of RIPK1 in Yersiniainduced cell death. Necrostatin-1 (Nec-1) inhibits RIPK1 kinase activity and prevents TLR-induced necrosis (21, 22) but was previously reported not to inhibit Yersinia pestis-induced cell death (10) . Surprisingly, we observed that both RIPK1-deficient BMDMs, and B6 BMDMs treated with Nec-1, exhibited reduced levels of Yp-induced caspase-1 and -8 processing (Fig. 1 A-D ) and cell death ( BMDMs are partially protected from Yersinia-induced death (17) . TLR4 signaling induces programmed necrosis in cells treated with the pan-caspase inhibitor zVAD-fmk via a TRIFand RIPK3-dependent pathway (21) . Interestingly, zVAD-fmk still sensitized Trif −/− BMDMs to cell death in response to WT Yp, but not YopJ-deficient Yp (ΔYopJ) infection, whereas B6 BMDMs were sensitized to both ( Fig. 1 E and F and Fig. S2C ). In contrast, Ripk1 −/− cells were not sensitized to death in the presence of zVAD-fmk in response to either ΔYopJ or Yp ( Fig.  1E and Fig. S2D ). These data indicate that YopJ induces cell death through RIPK1 via both TRIF-dependent and -independent pathways. Notably, although Nec-1 treatment protects Yp-infected cells from death, expression of NF-κB-dependent cytokines was not restored (Fig. S2 E-G) . These data demonstrate that YopJ-mediated blockade of cytokine production is independent of YopJ-induced cell death and imply that this cell death may serve an alternative function. Nec-1 did inhibit YopJinduced secretion of IL-18, consistent with its effect on caspase-1 activation (Fig. 1G) . Altogether, these data demonstrate a key role for RIPK1 in Yersinia-induced death and caspase-1 activation and suggest that this cell death functions as a host defense against pathogen blockade of inflammatory signaling pathways.
Caspase-8 Activity Is Required for YopJ-Induced Cell Death and Caspase-1 Processing. TLR signaling can trigger RIPK1-mediated cell death either via caspase-8 or RIPK3 (14, 21) . The observation that zVAD-fmk-treatment did not protect B6 BMDMs from Yp-induced death suggests either caspases are not required for Yp-induced cell death or blocking caspase activity in Ypinfected cells triggers cell death via RIPK3-mediated necrosis. Caspase-8 catalytic activity prevents a lethal RIPK3-dependent programmed necrosis that occurs in early embryonic development (23) . Notably, we found that Ripk3 −/− BMDMs had no defect in Yp-induced caspase-1 processing or cell death, whereas Ripk3 −/−
Casp8
−/− BMDMs failed to process caspase-1 or undergo cell death in response to Yp infection, in contrast to Salmonella (STm) or LPS+ATP treatment (Fig. 2 A-C) . This failure was not the result of insufficient back-crossing of these mice, because there were no single nucleotide variants between B6 and three different lines of 129 mice in caspase-8, cFLIP, FasL, or RIPK3, and the polymorphic genes immediately flanking caspase-8 are Grey peaks indicate uninfected cells. Error bars indicate mean ± SEM of triplicates and are representative of three or more independent experiments. ***P < 0.0001, **P < 0.001, *P < 0.01.
not linked to these cell death pathways (Fig. S3) . Importantly, in Ripk3 −/− BMDMs, zVAD-fmk abrogated Yp-induced death (Fig. 2C ). These data demonstrate that caspase inhibition induces RIPK3-dependent programmed necrosis in Yp-infected cells and that RIPK3 is not required for YopJ-induced caspase-1 processing or cell death in the presence of caspase-8. RIPK3 can activate caspase-1 in the absence of caspase-8 in response to LPS (24) or cIAP inhibitors (25) . Therefore, caspase-8 and RIPK3 might play redundant roles in caspase-1 activation or cell death during Yp infection. Intriguingly, conditional deletion of caspase-8 by inducible (ERT2-Cre), or developmental (LysM-Cre) approaches significantly reduced YopJ-mediated processing of caspase-1 in RIPK3-sufficient cells, indicating that caspase-8 and RIPK3 play a nonredundant role in YopJ-induced caspase-1 processing (Fig. 2D and Fig. S4A ). This caspase-8-dependent processing of caspase-1 was functionally important, because IL-18 secretion was significantly reduced in Ripk3 (Fig. 2E) . However, conditional deletion of caspase-8 was not sufficient to protect BMDMs from Yp-induced cell death ( Fig. S4 B and C) , in keeping with the finding that zVAD-fmk leads to programmed necrosis in RIPK3-sufficient cells. Importantly, caspase-1 activation in response to STm was completely unaffected in caspase-8 conditional BMDMs, indicating that these cells retained the ability to undergo inflammasome activation (Fig. S4D) . We also observed an apparent synergy between zVAD-fmk and Nec-1 in protection from LPS+ATP-treated cell death in B6 cells (Fig. 2C) . However, this is most likely because zVAD-fmk-pretreated cells that are then exposed to LPS+ATP undergo programmed necrosis, as Ripk3 −/− cells treated with zVAD-fmk followed by LPS+ATP are protected from cell death (Fig. 2C) .
To dissect how caspase-8 mediates activation of caspase-1, we reconstituted immortalized Ripk3 −/− Casp8 −/− (iR3 −/− C8 −/− ) macrophages with either WT caspase-8 (WT C8) or mutant caspase-8 lacking the three critical aspartate residues required for autoprocessing (D3A C8). Critically, expression of WT C8 but not of D3A C8 restored both Yp-induced cell death and processing of caspase-1 in iR3
C8
−/− cells (Fig. 2 F and G) . Both forms of caspase-8 were expressed at similar levels in the reconstituted cells, but the D3A mutant lacked catalytic activity, consistent with observations that noncleavable forms of caspase-8 do not exhibit catalytic activity in the absence of forced dimerization (26) (Fig. S5 A and B) . Noncleavable caspase-8 nonetheless retains some function, because it interacts with cFLIP to inhibit programmed necrosis and mediate protection from embryonic lethality (23, 27) . Consistently, zVAD-fmk treatment abolished both caspase-8 and caspase-1 processing in response to Yersinia infection, but not in STm-infected cells ( Fig.  S5 C-E). These data indicate that zVAD-fmk does not block the autoprocessing of caspase-1 that occurs in canonical inflammasomes but inhibits caspase-8-mediated caspase-1 processing. Altogether, these data indicate that the cleaved active caspase-8 homodimer mediates YopJ-induced processing of caspase-1. Inhibition of NF-κB and MAPK signaling by YopJ is necessary for Yp-induced cell death (28) , but whether this is responsible for RIPK1-and caspase-8-mediated caspase-1 activation is not known. Intriguingly, inhibition of both iκB kinase beta (IKKβ) and p38 MAPK induced RIPK1-dependent processing of caspase-8 and -1 and RIPK1-dependent death of ΔYopJ-infected cells (Fig. S6 ). Similarly to WT Yp infection, this cell death was largely unaffected in Ripk3 −/− cells but was abrogated in the absence of both RIPK3 and caspase-8. Together, these data demonstrate that YopJ-dependent inhibition of NF-κB and MAPK signaling triggers RIPK1/caspase-8-mediated caspase-1 activation.
FADD Is Required for Yp-Induced Caspase-1 Processing and Cell
Death. These findings, together with previous observations that YopP induces formation of a caspase-8, RIPK1, FADD complex (16) , and that FADD plays a role in apoptosis downstream of TRIF (14) , suggested that FADD might play a role in YopJinduced caspase-1 activation and cell death. Fadd −/− mice exhibit embryonic lethality that is reverted with loss of RIPK3 (29) . As anticipated, YopJ-induced caspase-1 processing was indeed abrogated in Ripk3 3A) , whereas STm-infected cells exhibited robust caspase-1 processing in the absence of RIPK3 and FADD ( Fig. 3 A and B) . Consistent with the recent study by Gurung et al. (30) , Ripk3
Fadd
−/− BMDMs also showed a noticeable reduction in LPS+ ATP-induced caspase-1 processing and cell death ( Fig. 3 B and  C) . Moreover, proinflammatory cytokine production in response to LPS alone was reduced in BMDMs lacking RIPK3 and caspase-8 or FADD (Fig. S7) , consistent with recent findings that pro-IL-1β expression is reduced in these cells (30) (31) (32) . Whereas Gurung et al. (30) observed that caspase-8 contributes to LPS+ ATP-induced canonical inflammasome activation, unlike with FADD deficiency, we did not observe a consistent reduction in caspase-1 processing in Ripk3
Casp8
−/− macrophages treated with LPS+ATP, and we were unable to detect caspase-8 processing in LPS+ATP-treated cells. The contribution of FADD and caspase-8 to LPS+ATP-induced caspase-1 activation may relate to differential effects on NLRP3 inflammasome priming.
YopJ-Induced Caspase-8 Activation Promotes Anti-Yersinia Immune Defense in Vivo. YopJ promotes dissemination of Yersinia to systemic tissues (33) . However, increasing YopJ-mediated cytotoxicity paradoxically enhances immune clearance and reduces virulence (34) . How this cytotoxicity contributes to host defense in vivo is not known. We therefore infected bone marrow chimeric mice lacking both RIPK3 and caspase-8 in the hematopoietic compartment, because these cells cannot undergo YopJ-inducd cell death. Critically, in contrast to B6, Ripk3 -/-, or littermate control bone marrow (BM) chimeras, mice with a caspase-8-deficient hematopoietic compartment rapidly succumbed to infection with a Yp strain that is nonlethal to WT mice (35) (Fig. 4A and Fig.  S8A) . Surprisingly, Ripk3
−/− chimeric mice were deficient in production of serum IFN-γ, IL-6, and IL-1β despite a severallog increase in bacterial cfu in infected tissues on day 6 postinfection, (Fig. 4 B and C and Fig. S8B ). Both innate and adaptive Ripk3
−/− cells failed to produce cytokines; inflammatory monocytes in the mesenteric lymph nodes (mLNs) and splenic natural killer (NK) cells were all defective in production of TNF-α, and IFN-γ at day 6 postinfection (Fig. 4 D-G and Fig. S8C ). In contrast, the chemokine MCP-1 was not affected in Ripk3 (Fig. 4B ). On day 3 postinfection, Ripk3
chimeras had a higher proportion of TNF-producing inflammatory monocytes in the spleen (Fig. S9B ), suggesting that caspase-8 deficiency in vivo does not lead to a failure of cell-intrinsic cytokine production per se. Cytokine production in the mLNs, where bacterial burdens were similar across genotypes, was defective on both days 3 and 5 ( Fig. S9 A-C ).
These findings demonstrate that combined deficiency of RIPK3 and caspase-8 results in severe susceptibility to WT Yp infection, but whether this is due to a failure to respond to the activity of YopJ or to a more global failure to induce immune responses was not clear. Importantly, Ripk3 −/− Casp8 −/− bone marrow chimeric animals were capable of surviving infection
Time post-infection (days) with ΔYopJ Yp, had significantly lower bacterial burdens of ΔYopJ in their spleen and liver, and partially recovered production of intracellular TNF (Fig. 5 A-C) . Despite elevated bacterial burdens, in the Ripk3
Casp8 −/− chimeras these mice had smaller splenic lesions that lacked close association of neutrophils with bacteria, compared with control caspase-8-sufficient chimeras, which had extensive lesions containing bacterial colonies surrounded by visible cell debris and neutrophilic infiltrates (Fig. 5D, Fig. S9 D and E, and Table S2 ). These data are consistent with reduced levels of in vivo death of Ripk3
chimeras showed significantly elevated numbers and extent of liver lesions compared with Yp-infected animals, suggesting that in the absence of NF-κB blockade the Ripk3 −/− Casp8 −/− cells can generate protective inflammatory responses that correlate with increased cell death in vivo (Fig. 5 E-G) . IL-1β (31, 32) . We now demonstrate that caspase-8, RIPK1, and FADD mediate caspase-1 activation in response to the Yersinia virulence factor YopJ, thus revealing an unanticipated integration of caspase-1 and caspase-8 death pathways in response to Yersinia infection.
We cannot currently exclude the possibility that RIPK3 and caspase-8 function redundantly to mediate cell death, or that RIPK3-mediated necrosis contributes to host defense against Yersinia. Nevertheless, in caspase- 8- (Fig. S10 ) whereby RIPK1, caspase-8, and FADD engage a cell death and caspase-1-activation pathway that promotes antimicrobial immune defense in response to pathogen-mediated interference with innate immune signaling pathways.
In addition to controlling cell-extrinsic death, caspase-8 also plays a role in NF-κB signaling and gene expression (31, 32, 38, 39) , potentially via cleavage of cFLIP (40, 41) . However, YopJinduced caspase-1 activation and cell death via caspase-8 and FADD are independent of LPS-induced priming, because they are triggered by NF-κB inhibition and are independent of ASC, NLRP3, and IFNAR. Indeed, LPS priming prevents YopJdriven cell death (6, 11) , either owing to up-regulation of NF-κB-dependent survival genes or inhibition of caspase-1 by YopM in LPS-primed cells (42) .
A previous study by Zheng et al. (43) observed a role for ASC in caspase-1 activation in Y. pestis-infected cells, in contrast to our studies here. YopJ isoforms from different Yersinia isolates exhibit different degrees of NF-κB inhibitory activity, and this also correlates with their degree of ASC/NLRP3 inflammasome activation. An alternative possibility is the slightly different infection conditions in the Zheng et al. study, which infected cells for 20 min prior to gentamicin treatment. Future studies will dissect the underlying basis for this apparent difference.
Finally, whether cell death or dysregulated cytokine production, or both, are directly responsible for the inability of caspase-8-deficient animals to clear Yersinia infection remains to be determined. The drop in cytokine production over the course of Yp infection in Ripk3
−/− chimeric mice may be due to increased blockade of signaling pathways as a consequence of progressively greater bacterial burden over time. Caspase-8-mediated cell death and caspase-1 activation in response to blockade of innate signaling may thus mobilize bystander cells for rapid cytokine production and/or phagocytosis of pathogen-associated cell debris.
Materials and Methods
Cell Culture and Infections. BMDMs were grown and infected as previously described (11) . Briefly, Yersinia were grown overnight with aeration in 2×YT broth at 26°C. On the next day, Yersinia were diluted into inducing media and grown with aeration for 1 h at 26°C followed by 2 h at 37°C. Salmonella was grown overnight in LB at 37°C with aeration, then diluted into high-salt LB and grown standing at 37°C. Cells were infected at a multiplicity of infection (MOI) of 20:1, centrifuged at 200 × g for 5 min, gentamicin (100 μg/ mL) was added 1 h after infection, and cells/supernatants were harvested at indicated time points. Caspase processing in cell lysates was analyzed by Western blotting, percent cytotoxicity was assayed by lactate dehydrogenase (LDH) release or propidium iodide (PI) uptake, and release of cytokines was analyzed by ELISA as described in SI Text. All statistical analyses were performed using the two-tailed unpaired Student t test. Yersinia (32777). Tissues and sera were collected on days 3, 5, and 6. Tissues were processed and plated on LB plates containing irgasan (2 μg/mL) to determine bacterial loads (colony-forming units per gram). Levels of serum cytokines were assayed by Luminex. Cells from spleens and mesenteric lymph nodes were cultured in the presence of brefeldin A and monensin for 5 h, stained for surface and intracellular cytokines, and analyzed by flow cytometry as described in SI Text. Spleen sections were fixed and stained for H&E. All animal studies were performed in accordance with University of Pennsylvania Institutional Animal Care and Use Committee approved protocols. xLysM-Cre bones were provided by Stephen Hedrick, University of California at San Diego, La Jolla. Fetal liver-derived macrophages (FLDMs) were grown from E12-14 livers in complete DMEM and 50% L929 supernatant for 7-9 d. Sixteen to twenty hours before infection cells were replated into 96-, 48-, 24-, or 12-well dishes in complete DMEM containing 10% L929 supernatant. Bacterial strains are described in Table S1 . Yersinia were grown overnight with aeration in 2×YT broth at 26°C. The bacteria were diluted into fresh 2×YT containing 20 mM sodium oxalate and 20 mM MgCl 2 (inducing media). Bacteria were grown with aeration for 1 h at 26°C followed by 2 h at 37°C. Salmonella were grown overnight in LB medium at 37°C with aeration, diluted into fresh LB containing 300 mM NaCl, and grown standing at 37°C for 3 h. Bacteria were washed three times with prewarmed DMEM, added to the cells at a multiplicity of infection (MOI) of 20:1 unless otherwise indicated, and spun onto the cells at 1,000 rpm for 5 min. Cells were incubated at 37°C for 1 h postinfection followed by addition of 100 μg/mL gentamicin. Necrostatin-1 (Nec-1) and zVAD-fmk were added 2 or 3 h before infection [30 μM or 60 μM Nec-1 (Calbiochem), 100 μM zVADfmk-001 (R & D Systems), 0.5 μg/mL Cytochalasin-D (Sigma), and 25 mM N-acetylcysteine (Sigma)]. IκB kinase beta (IKKβ) and p38 inhibitors were added 1 h before infection (BMS 345541 and SB202190; Millipore).
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4-Hydroxytamoxifen Treatment. The 4-hydroxytamoxifen (4-OHT) (50 nM, 98% pure Z-form; Sigma) was added on days 3 and 5 to indicated BMDMs in complete DMEM supplemented with 30% L929 supernatant. Cells were replated on day 7 and infections were performed as described above on day 8.
Western Blotting. All Yersinia infections, unless otherwise indicated, were performed with wild type Yersinia pseudotuberculosis strain IP2666 (Yp) or YopJ-deficient Yersinia pseudotuberculosis IP26 (ΔYopJ). Cell lysates were analyzed by Western blotting as described in ref. 1 . Briefly, cells were lysed in 20 mM Hepes, 150 mM NaCl, 10% glycerol, 1% Triton X-100, and 1 mM EDTA. Lysates were mixed with protein loading buffer, boiled, and centrifuged and 20% of the total cell lysate loaded onto 4-12% NuPAGE gels (Invitrogen). Proteins were transferred to PVDF membrane (Millipore) and blotted with rabbit antimouse caspase-1 antibody (sc-514; Santa Cruz Biotechnology), rat anti-mouse caspase-8 (clone 1G12, ALX 804-447-C100; Enzo Life Sciences), or mouse anti-mouse β-actin (Sigma). Secondary antibodies were goat anti-rabbit, goat anti-rat (Jackson Immunoresearch), or anti-mouse HRP (Cell Signaling Technology). Concentrations for lysis were calculated based on vol/vol.
Generation of Immortalized Cell Line. Freshly isolated Ripk3
−/−
Casp8
−/− bone marrow was infected with the v-myc/v-raf expressing J2-Cre retrovirus (2) and differentiated in 15% L929 supernatant. After 20 d in culture macrophages were weaned off L929 and passaged in complete-DMEM. Viral Transductions. WT C8 expression was accomplished by cloning full-length murine caspase-8 into the pBabe-Puro retroviral vector upstream of the T2A ribosomal skipping sequence followed by enhanced GFP. Mutations in murine D3A C8 were inserted at D387A, D397A, and D400A using the QuikChange Site Directed Mutagenesis kit (Agilent). D3A C8 was cloned into the pRRL-Puro lentiviral vector upstream of the T2A ribosomal skipping sequence followed by enhanced GFP. Cell Death Assays. Lactate dehydrogenase release. All Yersinia infections, unless otherwise indicated (as in Fig. 1G and Figs. S1B and S6) were performed with IP2666 (Yp) or IP26 (ΔYopJ). BMDMs were seeded into 96-well plates at a density of 7 × 10 4 cells per well in complete DMEM containing 10% L929 supernatant. Cells were infected as described above and supernatants harvested at indicated times postinfection. Lactate dehydrogenase (LDH) release was quantified using the Cytotox96 Assay Kit (Promega) according to the manufacturer's instructions. Cytotoxicity was normalized to Triton (100%) and LDH release from uninfected/untreated cells was used for background subtraction.
Propidium iodide uptake was analyzed by flow cytometry and confocal microscopy. Cells were seeded in 12-well suspension dishes at a density of 5 × 10 5 cells per well 16-20 h prior to infection. Cells were harvested with cold PBS at indicated times, washed twice with PBS, and stained with propidium iodide (PI) (Calbiochem), washed twice with PBS, run on an LSR Fortessa, and analyzed using FlowJo (TreeStar) software.
Kinetics of PI uptake was analyzed by time-lapse confocal microscopy.
Twelve-well chamber slides (ibidi) were coated with 1 mg/mL poly-L-lysine (Sigma) at 4°C 1 d before seeding cells. Cells were seeded at a density of 8-10 × 10 4 cells per well 16-20 h before infection. Four hours before infection, cells were loaded with Cell Tracker Green (Invitrogen) according to manufacturer's instructions, washed once, and replenished with fresh media. At time of infection, PI was added and PI uptake was analyzed using the inverted Leica DMI4000 based Yokagawa CSUX-1 spinning disk confocal microscope in a 37°C humidified chamber (Penn Vet Imaging Core) over indicated time points.
ELISAs and Luminex. BMDMs were pretreated with 50 ng/mL Escherichia coli LPS (Sigma) for 3 h before bacterial infection as described above, and supernatants were harvested 4 h postinfection. Release of proinflammatory cytokines was measured by ELISA using capture and detection antibodies against IL-6, IL-12, IL-1α (BD Pharmingen), or IL-1β (e-Bioscience). To detect IL-18 by ELISA (MBL International) from Yersiniainfected cells, BMDMs were infected (with LPS priming where indicated) and supernatants were harvested 4 h postinfection. Magnetic 20-plex Luminex (Invitrogen) was performed at the University of Pennsylvania Human Immunology Core to quantify cytokines and chemokines in mouse serum.
Caspase-8 Activity Assay. BMDMs were seeded into 96-well whitewalled plates at a density of 7 × 10 4 cells per well in complete DMEM containing 10% L929 supernatant. Cells were infected as described above with Ye or YeP− for 2 h. Media was aspirated and a 1:1 mix of PBS and Caspase-Glo 8 reagent+buffer (Promega) was added as per the manufacturer's protocol. Plates were allowed to shake at 300 rpm for 40 min before luminescence was read.
Mice. C57BL/6.SJL mice were obtained from Jackson Laboratories. All experiments were performed under Institutional Animal Care and Use Committee (IACUC) approved protocols and in accordance with the guidelines of the IACUC of the University of Pennsylvania. Six-to eight-week-old C57BL/6.SJL mice were lethally irradiated with 1,100 rads and 2-5 × 10 6 Ripk3
) and C57BL/6 (Jackson Laboratories) bone marrow (BM) cells were transferred i.v. BM chimeras were allowed to reconstitute for 8 to 10 wk. Mice were starved for 12-16 h and infected orally with 8-10 × 10 7 Yersinia (32777). Mice were killed and tissues and sera were harvested on days 3, 5, 6, and 7 postinfection, as indicated. Bacterial load was determined by plating dilutions of tissue homogenates on LB+irgasan plates and serum cytokines were measured by sandwich ELISA for IFN-γ (eBioscience).
Flow Cytometry. Spleens and mesenteric lymph nodes were isolated, red blood cells were lysed, and plated in complete-DMEM containing brefeldin A (Sigma) and monensin (BD) in a 37°C humidified incubator for 5 h. Cells were washed with FACS buffer (PBS with 1% BSA and 2 mM EDTA), fixed, and permeablized (BD) according to manufacturer's instructions and stained for CD19, NK1.1, CD45.1, CD45.2, B220 (BD), CD11b, viability (Invitrogen), Ly6C, CD3, CD11c, TNF, IFN-γ (eBiosciences), and Ly6G (BioLegend). Samples were run on an LSRFortessa and analyzed using FlowJo (TreeStar) software.
Histopathology. Spleens and livers were fixed and stained for hematoxylin and eosin. Sections were quantified by a blinded pathologist according to the metric in Table S2 .
Detection of Germ-Line Single-Nucleotide Variations and Small Insertion/Deletion. We downloaded whole-genome sequencing data from the Mouse Genomes Project of Wellcome Trust Sanger Institute (3). Using a pipeline that was initially developed for detecting somatic mutations using paired tumor/normal sample, we identified the germ-line single-nucleotide variations (SNVs) of the three 129 strains (129P2, 129S1, and 129S5) by running a paired SNV analysis using C57B6 as the reference sample. The initial variant calls were generated using variation detection module of Bambino (4) with the following parameters: -minflanking-quality 15 -min-alt-allele-count 2 -min-minor-frequency 0 -broad-min-quality 10 -mmf-max-hq-mismatches 15 -mmf-minquality 15 -mmf-max-any-mismatches 20 -unique-filter-coverage 2 -min-mapq 1. A postprocess pipeline filters SNVs in regions with low-quality regions and remaps (using the program BLAT) and realigns (using the program SIM) the reads harboring variant allele to the mouse mm10 genome to remove additional false calls. The validation rate for human cancer genome analysis is about 95% (5) , and that of mouse exome sequencing data are ∼90% (6).
Statistics. All statistical analyses were performed using the twotailed unpaired Student t test or Mann-Whitney U test, where indicated. Casp8 Locus
129S5
Gene of Interest
Casp8
Ripk3
Mcpt-ps1 
